Correspondence on 'Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis'

被引：2
作者：
Xu, Chuanhui [1 ]
机构：
[1] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore 308433, Singapore
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷 / 12期
关键词：
lupus erythematosus; systemic; antiphospholipid syndrome; antibodies; antiphospholipid;
D O I：
10.1136/annrheumdis-2020-219056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 8 条
[1]  
Fugate JE, 2015, LANCET NEUROL, V14, P874, DOI [10.1016/S1474-4422(15)00195-7, 10.1016/S1474-4422(15)00111-8]
[2]   Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus [J].
Kotzen, Elizabeth S. ;
Roy, Sanjeet ;
Jain, Koyal .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (05) :376-386
[3]   Multitarget Therapy for Induction Treatment of Lupus Nephritis A Randomized Trial [J].
Liu, Zhihong ;
Zhang, Haitao ;
Liu, Zhangsuo ;
Xing, Changying ;
Fu, Ping ;
Ni, Zhaohui ;
Chen, Jianghua ;
Lin, Hongli ;
Liu, Fuyou ;
He, Yongcheng ;
He, Yani ;
Miao, Lining ;
Chen, Nan ;
Li, Ying ;
Gu, Yong ;
Shi, Wei ;
Hu, Weixin ;
Liu, Zhengzhao ;
Bao, Hao ;
Zeng, Caihong ;
Zhou, Minlin .
ANNALS OF INTERNAL MEDICINE, 2015, 162 (01) :18-U154
[4]   Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis [J].
Mok, Chi Chiu ;
Ho, Ling Yin ;
Ying, Shirley King Yee ;
Leung, Man Chi ;
To, Chi Hung ;
Ng, Woon Leung .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (08) :1070-1076
[5]   Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up [J].
Mok, Chi Chiu ;
Ying, King Yee ;
Yim, Cheuk Wan ;
Siu, Yui Pong ;
Tong, Ka Hang ;
To, Chi Hung ;
Ng, Woon Leung .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) :30-36
[6]   A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis [J].
Rovin, Brad H. ;
Solomons, Neil ;
Pendergraft, William F., III ;
Dooley, Mary Anne ;
Tumlin, James ;
Romero-Diaz, Juanita ;
Lysenko, Lidia ;
Navarra, Sandra V. ;
Huizinga, Robert B. .
KIDNEY INTERNATIONAL, 2019, 95 (01) :219-231
[7]   Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions [J].
Wu, Li-Hua ;
Yu, Feng ;
Tan, Ying ;
Qu, Zhen ;
Chen, Meng-Hua ;
Wang, Su-Xia ;
Liu, Gang ;
Zhao, Ming-Hui .
KIDNEY INTERNATIONAL, 2013, 83 (04) :715-723
[8]   Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study [J].
Zavada, J. ;
Pesickova, S. S. ;
Rysava, R. ;
Olejarova, M. ;
Horak, P. ;
Hrncir, Z. ;
Rychlik, I. ;
Havrda, M. ;
Vitova, J. ;
Lukac, J. ;
Rovensky, J. ;
Tegzova, D. ;
Boehmova, J. ;
Zadrazil, J. ;
Hana, J. ;
Dostal, C. ;
Tesar, V. .
LUPUS, 2010, 19 (11) :1281-1289
1